Ina Research Inc
TSE:2176
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Ina Research Inc
Cash Interest Paid
Ina Research Inc
Cash Interest Paid Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
Ina Research Inc
TSE:2176
|
Cash Interest Paid
¥26m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-3%
|
|
|
Carna Biosciences Inc
TSE:4572
|
Cash Interest Paid
¥3.6m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
4%
|
|
|
S
|
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
|
Cash Interest Paid
¥249.6m
|
CAGR 3-Years
29%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-1%
|
|
|
Medinet Co Ltd
TSE:2370
|
Cash Interest Paid
¥7k
|
CAGR 3-Years
-59%
|
CAGR 5-Years
-59%
|
CAGR 10-Years
-52%
|
|
|
Immuno-Biological Laboratories Co Ltd
TSE:4570
|
Cash Interest Paid
¥2.9m
|
CAGR 3-Years
43%
|
CAGR 5-Years
30%
|
CAGR 10-Years
1%
|
|
|
D
|
DNA Chip Research Inc
TSE:2397
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Ina Research Inc
Glance View
Ina Research, Inc. engages in the development of pharmaceutical products. The company is headquartered in Ina-Shi, Nagano-Ken and currently employs 194 full-time employees. The company went IPO on 2008-06-25. The firm operates in two business segments. The Contract Test segment is engaged in the provision of non-clinical test services to confirm the safety and efficacy of developed pharmaceuticals and food materials based on laboratory animals and cells for pharmaceutical development companies, food-related companies, research institutes and others. The Environmental segment is engaged in the design and sale of animal facilities for pharmaceutical companies and universities, deodorant-loaded devices, sterilization equipment, equipment for laboratory animals and others.
See Also
What is Ina Research Inc's Cash Interest Paid?
Cash Interest Paid
26m
JPY
Based on the financial report for Mar 31, 2022, Ina Research Inc's Cash Interest Paid amounts to 26m JPY.
What is Ina Research Inc's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 10Y
-3%
Over the last year, the Cash Interest Paid growth was -10%. The average annual Cash Interest Paid growth rates for Ina Research Inc have been -7% over the past three years , -9% over the past five years , and -3% over the past ten years .
